// App-Quantinova.ai

PO‐100 : Evaluating the use of multi‐parametric flow cytometry in the assessment of minimal residual disease and treatment response following autologous stem cell transplant in patients with myeloma

Researchers

Presenter

  • S Khanna

Principal Investigators

  • A Dunlop

  • D Yallop

  • R Ireland

  • S Kassam

Medical Centers

  • Haematological Medicine, Kings College Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • Cluster of Differentiation 38

  • Cluster of differentiation 45

  • Cluster of Differentiation 5

  • Cluster of Differentiation 56

  • KIT Proto-Oncogene, Receptor Tyrosine Kinase

  • Syndecan-1

Drug/Treatment

  • Lanthanum carbonate

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved